Where to Give Mounjaro Shots: The Facts, Not the Myths

The myth: stick to your stomach and you're fine

It is one of the most repeated pieces of unofficial advice in online groups: inject only into the abdomen because it's the most reliable site. The problem is that no head-to-head pharmacokinetic data support this preference for tirzepatide, and the advice actively discourages what the prescribing information recommends, rotating across all three sites. The stomach is a perfectly valid site. So is the thigh. So is the upper arm. The licensed guidance treats them as equivalent options, and the whole point of rotation is to give each area time to recover between doses.

Lipohypertrophy is the technical name for the firm, rubbery lumps that develop when the same patch of subcutaneous tissue is punctured week after week. It is not just a cosmetic issue. Studies in people using insulin have shown that injecting into affected tissue produces erratic absorption, and while Mounjaro is not insulin, the underlying tissue response is the same. Varying your sites, and varying the precise spot within each site, is the single most practical thing you can do to keep absorption consistent. If you have been rotating conscientiously and want to understand the wider Mounjaro injection process in more detail, there is guidance on the full technique.

Exactly where on each site to inject

Knowing that the abdomen is a valid site is not the same as knowing where on the abdomen to inject. The SmPC guidance is specific: stay at least 5 cm away from the navel. The skin around the navel is thicker and less consistent; injecting too close can increase discomfort and variability. Within the abdomen, you have a large oval of usable skin to work with, roughly from the lower ribcage down to the hip bones and out toward the flanks, excluding that central 5 cm radius.

For the thigh, aim at the front and outer surface, roughly the middle third of the leg. The inner thigh has more variable fat depth and more discomfort, so it is not recommended. Upper arm injections typically use the outer, slightly fleshy area of the middle third, the part a practice nurse would also choose for a flu jab. Many people find self-injecting the upper arm awkward without a mirror or a second person; it is the site most commonly skipped, which defeats the rotation goal. A detailed breakdown of injection locations by body region covers the landmarks for each site if you want to map them out before your first pen.

Wherever you inject, choose a fresh spot a few centimetres from wherever you injected the week before. If you want practical guidance on where to do your Mounjaro shot, including how to position the pen and find the right area, that is covered in detail for each site. A simple mental map works: think of the abdomen as a clock face and move one hour per injection.

Preparing the site and the pen

Cleaning the skin is straightforward: alcohol swabs wipe the area and then dry for at least 30 seconds before injecting. Injecting onto wet alcohol stings. The Mounjaro KwikPen is pre-filled and comes straight from the fridge, allow it a couple of minutes at room temperature if you find cold injections uncomfortable, though this is not clinically required.

Pinching the skin before inserting the needle is generally recommended for leaner injection sites, particularly the thigh. For the abdomen, where subcutaneous fat tends to be more generous, pinching is usually unnecessary but does no harm. Press the pen firmly against the skin, press the button and hold for the full count the pen instructions specify, releasing early can mean an incomplete dose. After the injection, do not rub the site; just apply light pressure for a few seconds. Dispose of the used pen in a dedicated sharps container, not in ordinary household waste.

Storage matters here too. Mounjaro pens are refrigerated between 2°C and 8°C; the exact period for which a pen can be kept at room temperature once removed is stated in the Patient Information Leaflet, and that figure is the one to follow. A practical routine that works well for many patients is keeping the current pen in the fridge door, separate from the next one in the box, so there is no confusion about which pen has been opened.

When to tell your prescriber about a site problem

Mild injection-site reactions are common. The NHS tirzepatide guidance lists redness, bruising and skin irritation at the injection site among expected side effects. These are not reasons to stop treatment; they usually resolve within a few days. What warrants a conversation with your prescriber: a firm lump or area of thickened skin that does not resolve between doses (suggesting lipohypertrophy), persistent swelling or pain beyond a few days, or any sign of infection such as increasing warmth, redness spreading outward, or discharge.

A prescriber can also advise you if you are finding all three sites genuinely difficult, for example because of limited subcutaneous fat, a skin condition, or restricted arm mobility. There may be practical adjustments to make. If you are considering treatment and want to understand what clinical assessment looks like before your first pen arrives, our guide to giving the Mounjaro injection walks through the full process from needle removal to aftercare. Cost context, if you are weighing up a private prescription, is covered on our Mounjaro price comparison page. When you are ready to move forward, starting a free consultation is the first step, a GPhC-registered prescriber reviews your answers the same day.